Videos

Sessions focuses on new diabetes treatment options.

In this clip, Jeffrey Fudin, PharmD, who spoke at APHA 2017 on opioid tapering, discusses options pharmacists should consider when tapering patients.

In this clip, Jeffrey Fudin, PharmD, discusses available options in abuse-deterrent formulations of opioids.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Grant E. Knowles, PharmD, vice president of Business Development at Ardon Health, discusses the potential impact of value-based care on specialty pharmacy.

Jonathan Van Lare, PharmD, director of Clincal Services at Pharmacy Advantage, discusses the elements of a successful specialty pharmacy therapy management program.

Marc O'Connor, COO and chief strategy officer of Curant Health, discusses increased oversight of specialty medication pricing.

Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses whether increased competition for specialty drugs can lower costs.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses methods pharmacists can employ to maintain adherence.

Daniel P. Kus, BS Pharm, RPh, vice president, Pharmacy Advantage, discusses key quality measures that define successful specialty pharmacies.

Mark Tesell, PharmD, BCPS, discusses how the high cost of PCSK9 inhibitors effected uptake of the cholesterol-lowering drug.

Paul LeVine, vice president of Analytic Services at Trial Card, discusses potential ways to overcome the hurdle of limited access to high cost specialty drugs.

Mark A. Vineis, vice president of specialty pharmacy at Cardinal Health, discusses the elements of a successful therapy management program in specialty pharmacy.

Marc O'Connor, COO and chief strategy officer for Curant Health, discusses how specialty pharmacies can demonstrate value as the use of value-based care designs increase.

Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses utilization management issues with a PCSK9 inhibitor regimen for high cholesterol.

Deborah Michaelson, MS, RPh, discusses various challenges that accompany patient support in the long-term care setting.

Gregory R. Morris, chief commercial officer at VirMedica, discusses hurdles with the use of eAccess technology in specialty pharmacy.

Grant E. Knowles, PharmD, vice president of Business Development at Ardon Health, discusses how specialty pharmacies can help patients access high cost specialty drugs.

Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses how collaborative care programs among providers can benefit patients undergoing treatment.

Marc O'Connor, COO and chief strategy officer at Curant Health, discusses how the shift to Medicare Part D could impact patients undergoing treatment for cancer.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses how specialty pharmacy can best utilize data analytics.